Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Endoscopy International Open|April 13, 2026
Correction: Clinical feasibility of gastric endoscopic submucosal dissection in patients on glucocorticoids or immunomodulators: Propensity-score-matched studyHiroki Fukuya, Eikichi Ihara, Yoichiro Iboshi, et al.Respiratory Investigation|June 1, 2026
Clinical significance of <sup>18</sup>F-FDG uptake in interstitial lung lesions in lung cancer patients with interstitial lung disease treated with immune checkpoint inhibitor therapyTsuguhiro Furukawa, Kimitaka Akaike, Koichi Saruwatari, et al.BMC Pulmonary Medicine|April 4, 2019
Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancerShohei Hamada, Hidenori Ichiyasu, Tokunori Ikeda, et al.Journal of Clinical Medicine|June 1, 2019
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal AntibodiesRyo Sato, Kosuke Imamura, Shinya Sakata, et al.International Journal of Molecular Sciences|November 26, 2022
Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung CancerKosuke Imamura, Yusuke Tomita, Ryo Sato, et al.Journal of Medicinal Chemistry|August 6, 2010
Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitorsShohei Hamada, Takayoshi Suzuki, Koshiki Mino, et al.Journal of Thoracic Disease|November 17, 2022
Clinical impact of SUV<sub>max</sub> of interstitial lesions in lung cancer patients with interstitial lung disease who underwent pulmonary resectionKimitaka Akaike, Koichi Saruwatari, Ryohei Matsushima, et al.Oncoimmunology|June 3, 2022
<i>Clostridium butyricum</i> therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitorsYusuke Tomita, Yoshihiko Goto, Shinya Sakata, et al.Internal Medicine (Tokyo, Japan)|February 14, 2020
Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab TreatmentKei Nakashima, Koichi Saruwatari, Ryo Sato, et al.Cancers|January 11, 2024
Association of <i>Clostridium butyricum</i> Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy CombinationsYusuke Tomita, Shinya Sakata, Kosuke Imamura, et al.Pageof 7